Pelvic organ prolapse surgical mesh

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Overall sexual activity rates increased from 57.3% at baseline to 62.8% at 12 months after prolapse surgery (OR 1.2, 95% CI 1.1-1.4). Of women not sexually active at baseline, 25.4% (101/398) became s

Effect: improvement; OR 1.2; CI: 95% CI 1.1 – 1.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4

Among 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI

Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4